Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antibodies to ...

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

Synaffix adds to the flurry of ADC dealmaking as it partners with Boehringer and Mitsubishi Tanabe with deals announced on the same day.

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

In a milestone for cellular research, eMBR Genomics and Axio BioPharma announce the first commercial availability of MKLP1 ...

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

Women are less likely to receive a lung transplant than men and wait longer on the waiting list, but they have significantly ...

The U.S. Centers for Disease Control and Prevention (CDC) currently recommends that everyone 75 and older receive a single ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...